(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
...
Geert R Kersten, Director and CEO, purchased 25,000 shares of Cel-Sci (CVM) on Jul 06, 2021, for $200,000. After the Form 4 filing with the SEC, Kersten...
Cel-Sci (CVM) said Wednesday that it will hold an investor call on Thursday at the end of its annual shareholder meeting to discuss phase 3 head and neck...
Cel-Sci (CVM) said Monday that its Multikine immunotherapy yielded significant overall survival benefit in patients with advanced and primary squamous cell...
Cel-Sci (CVM) said Friday it closed its offering of 1.4 million common shares priced at $22.62 each for gross proceeds of about $31.7 million. The company...
Health care stocks were advancing premarket Wednesday. The Health Care SPDR (XLV) was 0.27% higher and the iShares NASDAQ Biotechnology Index (IBB) was...
US stocks were set for narrow gains Wednesday as traders remained on the sidelines awaiting fresh catalysts from a reading on US inflation later in the...
Cel-Sci (CVM) on Tuesday increased its previously announced bought-deal offering to 1.4 million common shares from 1 million shares due to demand. The...